Atrial fibrillation and cancer patients: mechanisms and management

DL Madnick, MG Fradley - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cancer-related mortality has significantly declined over the past
several decades as a result of improved screening, diagnostics, and therapeutics. Although …

[HTML][HTML] Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

C Pawlyn, DA Cairns, T Menzies, JR Jones… - …, 2022 - ncbi.nlm.nih.gov
Autologous stem cell transplant (ASCT) remains the standard of care for consolidation after
induction therapy for eligible patients with newly diagnosed myeloma. In recent clinical trials …

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma …

GY Song, SH Jung, JS Kim, HS Eom, JH Moon… - Frontiers in …, 2022 - frontiersin.org
Background Autologous stem cell transplantation (ASCT) remains the standard of care for
patients with newly diagnosed multiple myeloma (MM). Several attempts to improve the …

Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study

A Rago, O Annibali, V Tomarchio… - European Journal of …, 2022 - Wiley Online Library
High‐dose chemotherapy followed by autologous stem cell transplantation (auto‐SCT) is
the standard treatment for young patient≤ 65 years with multiple myeloma (MM). The role of …

[HTML][HTML] 老年多发性骨髓瘤患者接受自体造血干细胞移植的疗效和安全性: 单中心回顾性研究

黄蓓晖, 李娟, 邹外一, 刘俊茹, 谷景立… - Chinese Journal of …, 2022 - ncbi.nlm.nih.gov
老年多发性骨髓瘤患者接受自体造血干细胞移植的疗效和安全性:单中心回顾性研究- PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

[HTML][HTML] Long-term Effects of Regular Whole Blood Donation on Peripheral Blood CD34+ Cells Population with using Leukoreduction Filters

PA Sourki, AA Pourfathollah, M Pakjoo… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Methods: Samples (n= 20) were obtained from 10 first-time donors and 10 regular blood
donors with more than 30 times blood donation. After separating leukocytes from LRFs by …

[HTML][HTML] Guidelines on the diagnosis and management of multiple myeloma treatment: Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular …

A Maiolino, EQ Crusoé, GA Martinez… - … , Transfusion and Cell …, 2022 - SciELO Brasil
SciELO - Brasil - Guidelines on the diagnosis and management of multiple myeloma treatment:
Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines …

Funktionelle Validierung von seltenen KRas-Mutationen in Zelllinien des Multiplen Myeloms

LF Großhans - 2022 - opus.bibliothek.uni-wuerzburg.de
Das Multiple Myelom (MM) ist eine seltene, maligne Störung der Plasmazellen, welche trotz
gehöriger Therapiefortschritte in den letzten Jahrzehnten nach wie vor als unheilbare …

Transplante autólogo de células-tronco hematopoiéticas no paciente com idade maior ou igual a 60 anos com mieloma múltiplo: avaliaçao de mortalidade …

MJ Atanazio - 2022 - teses.usp.br
INTRODUÇÃO: O transplante autólogo de células-tronco hematopoiéticas (TaCTH) é um
dos pilares no tratamento do mieloma múltiplo (MM). Embora seu uso já esteja bem …

[PDF][PDF] Auswirkung der Melphalan-Dosierung zur Konditionierung vor autologer Stammzelltherapie bei PatientInnen mit einem Multiplen Myelom: eine retrospektive …

F Hofe - 2022 - db-thueringen.de
2 ZUSAMMENFASSUNG Zur Konditionierungstherapie vor autologer
Stammzelltransplantation (ASZT) bei PatientInnen mit Multiplem Myelom (MM) wird …